Cargando…
The experience of treating patients with acute myocardial infarction under the COVID‐19 epidemic
Worldwide Coronavirus Disease 2019 (COVID‐19) epidemic makes the management of acute myocardial infarction (AMI) more complicated, effective treatment without further dissemination is thus quite challenging. Recently, we successfully treated three representative AMI cases, by sharing these detailed...
Autores principales: | Xiao, Zhichao, Xu, Chang, Wang, Daowen, Zeng, Hesong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267329/ https://www.ncbi.nlm.nih.gov/pubmed/32348003 http://dx.doi.org/10.1002/ccd.28951 |
Ejemplares similares
-
Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial
por: Ploumen, Eline H., et al.
Publicado: (2021) -
Education level and outcomes after acute myocardial infarction in China
por: Huo, Xiqian, et al.
Publicado: (2019) -
Peripheral artery disease and outcomes in patients with acute myocardial infarction
por: Attar, Rubina, et al.
Publicado: (2019) -
Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic
por: Mohammad, Moman A, et al.
Publicado: (2020) -
Resilience as a correlate of acute stress disorder symptoms in patients with acute myocardial infarction
por: Meister, Rebecca E, et al.
Publicado: (2015)